Hepatitis C and HIV Testing in Residential Treatment: The CDC Screening Rules, the Six-Month Window, and What to Ask Admissions

Most people arriving at residential treatment are focused on getting through detox and the first few days. Bloodwork for hepatitis C and HIV is rarely on their mind, and families often learn about it only when a result comes back and nobody is sure what it means. Yet the intake period is one of the most practical moments in a person’s life to get screened, because a clinical team is already drawing labs, someone is following up, and there is time to start a plan before discharge.

This guide explains what the current federal testing recommendations say, how the tests actually work, where the process tends to break down, and the specific questions to ask admissions before or during the first week. If you want to talk through a specific situation, call our team at (877) 328-1968.

What the CDC Recommends, in Plain Terms

The CDC recommends that every adult 18 and older be tested for hepatitis C at least once in their lifetime, and that everyone between the ages of 13 and 64 be tested for HIV at least once. For people who share needles, syringes or other injection equipment, the CDC recommends HIV testing at least once a year and periodic hepatitis C testing for as long as the risk continues. A person entering residential treatment who has injected drugs even once, even long ago, falls inside the hepatitis C testing recommendation, and a reactive hepatitis C antibody test is not by itself a diagnosis: a second test for the virus itself (an HCV RNA test) is what confirms a current infection. Current hepatitis C treatment can cure most people within 8 to 12 weeks, according to the CDC. (Recommendations checked at CDC hepatitis C testing guidance and CDC HIV testing guidance on October 14, 2026.)

Note that these recommendations are not limited to people who inject. The CDC’s hepatitis C screening recommendation covers all adults, and its HIV recommendation calls for yearly testing for anyone who has exchanged sex for drugs or money, had more than one sex partner since their last test, or been treated for another sexually transmitted infection, hepatitis or tuberculosis. Substance use of any kind can raise those risks, which is why many programs offer screening to everyone rather than only to people who report injection.

How the Tests Work, and Why Results Confuse People

Much of the anxiety around these results comes from not knowing that screening happens in steps. Understanding the sequence prevents a lot of unnecessary fear.

• Hepatitis C antibody test: shows whether a person has ever been infected, not whether they are infected now, because antibodies stay in the blood even after the virus is cleared or cured.
• HCV RNA test (nucleic acid test): looks for the virus itself and is what confirms a current infection after a reactive antibody result.
• Rapid point-of-care tests: use a small blood sample and can return a result in about 30 minutes, per the CDC, but a reactive rapid result still needs lab confirmation.
• HIV antigen/antibody lab tests: are the type the CDC recommends for lab testing, and they look for both antibodies and the p24 antigen, which can be detected before antibodies develop.
• Recent exposure: if someone may have been exposed to hepatitis C in the past six months, the CDC says an RNA test should be ordered instead of an antibody test, because antibodies may not have developed yet.

That last point matters in residential treatment specifically. Many people arrive within days or weeks of their last use. A negative antibody test drawn on day two does not rule out an exposure from two weeks earlier, and the care team needs to know about recent risk to choose the right test.

Why the Timing Problem Is the Real Issue

In treatment consultation work, the most common failure we see is not a refusal to test. It is a result that arrives after the person has already left. Send-out lab work, and especially confirmatory RNA testing, can take days to come back. If the person discharges before the follow-up conversation, a reactive result may sit in a chart with no one assigned to act on it.

The second timing gap is treatment length. Hepatitis C treatment typically runs 8 to 12 weeks, which can be longer than a residential stay. That means treatment, if started, usually has to continue with an outpatient prescriber, and the handoff is where people get lost. A residential stay is often the most stable stretch of time a person has had in months, which makes it a good moment to begin, as long as the outpatient prescriber is lined up before discharge.

An honest, inconvenient truth: some programs do not draw these labs on site and instead refer out. That is not automatically a problem, but it means you need to know who owns the follow-up before you arrive.

What to Ask Admissions Before Arrival

These are questions you can ask on your next call with any program, including ours at (877) 328-1968. Write the answers down.

1. Do you offer hepatitis C and HIV screening during intake, and is it opt-out or by request? Opt-out screening means it is offered to everyone unless the person declines.
2. Are labs drawn on site, or is the person sent to an outside lab or clinic? This affects how quickly results return.
3. If an antibody test is reactive, is the confirmatory RNA test run automatically from the same sample? Reflex testing avoids a second blood draw and a delay.
4. Who reviews the result with the patient, and how fast? Ask for a role, such as the medical director or nurse practitioner, not just “the team.”
5. If treatment is needed, will it start during the stay, and who prescribes after discharge? Ask whether the outpatient prescriber is named in the discharge plan.
6. Is the cost covered by insurance or billed separately? Screening is often covered as preventive care, but confirmatory testing and treatment may follow different rules. Our insurance verification page can help you start that check.

Something You Can Do Today

Before admission, gather two pieces of information and give them to the intake nurse: the date of any prior hepatitis C or HIV test and its result, and the approximate date of the most recent possible exposure, such as shared injection equipment or unprotected sex. If you have an old lab report on a patient portal, take a screenshot. That single step lets the clinical team decide between an antibody test and an RNA test on day one instead of discovering the gap a week later.

If you are a family member, you cannot request results without the person’s written consent. Federal confidentiality rules for substance use treatment records are strict. What you can do is encourage your loved one to sign a release that covers medical updates, and ask admissions which form that is.

Safety First During the Early Days

Lab screening is never the priority over a safe withdrawal. Withdrawal from alcohol and benzodiazepines can cause seizures and can be life-threatening, and it requires medical supervision. Anyone with recent heavy use of either substance should be assessed for medically managed detox before or at the start of residential treatment. Opioid withdrawal is rarely fatal by itself, but returning to use after a period of abstinence carries a high overdose risk because tolerance falls quickly. The National Institute on Drug Abuse notes that illicitly manufactured fentanyl now drives most overdose deaths and may be present in other drugs without the buyer knowing.

If you or someone you love is in crisis, call or text 988 to reach the 988 Suicide & Crisis Lifeline. For free, confidential treatment referrals at any hour, the SAMHSA National Helpline is available at 1-800-662-4357.

How This Fits Into a Full Treatment Plan

A positive result for hepatitis C or HIV is news that deserves time and support, and it can be heavy to receive early in recovery. A well-run program treats it as part of the care plan rather than a side issue: counseling staff are aware, the person is not left alone with the result, and the discharge plan names who will carry treatment forward. A negative result is useful too, because it gives a baseline and is a natural moment to talk about prevention, including access to sterile supplies and pre-exposure prophylaxis (PrEP) for HIV where appropriate.

For a broader view of how programs coordinate medical and behavioral care, see our overview of addiction treatment. Our team in Northern California can walk you through what intake looks like, which labs are typically drawn, and what to bring. Call (877) 328-1968 to talk with someone today.

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Testing and treatment decisions should be made with a licensed healthcare provider who knows your history. If you are experiencing a medical emergency, call 911.